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Abstract
Objective—To better understand the knowledge, attitudes and practices of obstetrician-
gynecologists with respect to screening and treatment for iron deficiency anemia (IDA).
Methods—A total of 1,200 Fellows and Junior Fellows of the American College of Obstetricians 
and Gynecologists were invited to participate in a survey on blood disorders. Respondents 
completed a questionnaire regarding their patient population, screening and treatment practices for 
IDA, and general knowledge about IDA and its risk factors.
Results—Overall response rate was 42.4%. Thirty-eight percent of respondents screen non-
pregnant patients regularly, based on risk factors; 30.5% screen only when symptoms of anemia 
are present. For pregnant patients, 50.0% of respondents screen patients at their initial visit, while 
46.2% screen every trimester. Sixty-one percent of respondents supplement pregnant patients 
when there is laboratory evidence of anemia; 31.6% supplement all pregnant patients. Forty-two 
percent of respondents screen post-partum patients based on their risk factors for IDA. However, 
when asked to identify risk factors for postpartum anemia, slightly more than half of respondents 
correctly identified young age and income level as risk factors for post-partum anemia; only 
18.9% correctly identified pre-pregnancy obesity as a risk factor.
Conclusion—There are opportunities for increased education on IDA for obstetrician-
gynecologists, specifically with respect to risk factors. There also appears to be substantial 
practice variance regarding screening and supplementation for IDA, which may correspond to 
variability in professional guidelines. Increased education on IDA, especially the importance of 
sociodemographic factors, and further research and effort to standardize guidelines is needed.
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Iron deficiency anemia (IDA) is a global health issue. The World Health Organization ranks 
IDA in the top-20 causes of disability-adjusted life-years lost, ahead of tuberculosis (World 
Health Organization 2013). Worldwide, the number of non-pregnant women affected by IDA 
is well over 400 million, making this the population group with the largest number of 
affected individuals (World Health Organization 2008). Prevalence of IDA among pregnant 
women worldwide is 41.8, and 30.2% among non-pregnant women (World Health 
Organization 2008). In the United States, monitoring of iron status is limited, but 
approximately 4% of women between the ages of 12 and 49 have IDA (Cusick et al. 2008). 
Among pregnant women in the United States, iron deficiency prevalence is 18.6%, and 
approximately 16% of these women are anemic (Mei et al. 2011). Racial and ethnic 
disparities exist, with 12% of black women and 8% of Mexican-American women being 
affected by IDA, as compared with 3% of non-Hispanic white women (Cusick et al. 2008).
IDA is associated with a number of adverse health consequences for both women and their 
children. IDA in pregnancy is associated with preterm delivery and low birth-weight (Scholl 
and Reilly 2000). IDA in pregnancy may also contribute to poorer cognitive development 
and IDA among children (Radlowski and Johnson 2013), and has been implicated in the 
development of post-partum depression (Albacar et al. 2011). A recent study showed that 
IDA was an independent risk factor for maternal transfusion, preterm delivery, 5 min 
APGAR less than seven, and NICU admission (Drukker et al. 2015), and associated a 1 g/dL 
increase in hemoglobin with an approximate 8% decrease in risk for Cesarean section 
(Drukker et al. 2015). Most cases of IDA are easily treated by dietary supplementation when 
identified (Johnson-Wimbley and Graham 2011).
Obstetrician-gynecologists are in a unique position to care for the general health of both 
pregnant and non-pregnant women. Given the importance of IDA as a health concern for 
women in general, and pregnant women, in particular, we investigated knowledge, attitudes 
and practices surrounding screening and treatment for IDA among obstetricians and 
gynecologists.
Materials and Methods
The American Congress of Obstetricians and Gynecologists (ACOG) selected 1200 fellows 
and junior fellows in current practice in December, 2009 to receive a survey questionnaire. 
Of these, 600 were members of the Collaborative Ambulatory Research Network (CARN), 
who voluntarily agree to participate in survey research. The additional 600 were randomly 
selected fellows and junior fellows outside of the CARN. The survey was mailed to 
recipients up to four times before they were counted as non-responders.
The survey included questions about physician demographics, training, practice 
characteristics, and patient population. Questions assessed self-reported practices for 
screening non-pregnant, pregnant and postpartum patients, supplementation of pregnant 
patients, and knowledge about IDA and risk factors. The survey questions did not specify a 
time-frame that they referred to, such as “for patients over the last year;” responses were 
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therefore assumed to refer to a respondent's current practices, offering a cross-sectional view 
of practices in time. Physicians were also asked to rate the training they had received in 
medical school and residency, together, on IDA screening, assessment and treatment as 
comprehensive, adequate, barely adequate, inadequate, or nonexistent. These ratings were 
left undefined and were meant to assess how physicians felt their training on IDA in medical 
school and residency prepared them for practice, not as an objective measure of how much 
training on IDA they had actually received.
This project was approved by the ACOG institutional review board (IRB) and was approved 
on December 10, 2009, IRB #05. Statistical analysis was performed using SPSS (version 16, 
Chicago, IL).
Results
Of the 1200 eligible survey participants, 15 could not be reached. A total of 503 surveys 
were available for analysis, giving a total response rate of 42.4% (503/1185). Of these 503 
respondents, 338 (67.2%) were CARN members. No differences in demographics were 
found between CARN responders and non-CARN responders in previous studies utilizing 
this survey data (Byams et al. 2012), allowing the samples to be combined for analysis.
Respondents had been in practice for a mean of 18.8 years, and a majority (72.6%) 
described their primary specialty as general obstetrics-gynecology (Table 1). Respondents 
most frequently reported that their patients lived in urban areas (40.9%), with non-Hispanic 
white patients, on average, making up the largest percentage of patients seen in respondents' 
practices (59.3%, Table 1).
The vast majority of physicians surveyed rated their training in each IDA-specific domain 
(screening, assessment and treatment) as either comprehensive or adequate. Absolute 
numbers of respondents rating their training as inadequate were small, with seven rating 
training on screening or treatment and six rating training on assessment as such. More 
respondents rated their training on assessment as barely adequate or inadequate than for 
screening or treatment (13.4 vs. 9.7 and 12.0%, respectively). No respondents rated their 
training on IDA as nonexistent.
Respondents most commonly reported screening non-pregnant and post-partum patients 
based on unspecified risk factors (Table 2), although several also reported screening all non-
pregnant and post-partum patients regularly. Thirty percent (30.5%) of respondents reported 
screening non-pregnant patients only when patients were symptomatic, comparable to 28% 
of respondents who screen post-partum patients only when symptomatic (Table 2). 
Screening for pregnant women revealed a dichotomy in terms of when patients are screened, 
with half (50%) of respondents who reported that they see pregnant patients screening 
pregnant women at their initial visit and nearly half (46.2%) screening pregnant women 
every trimester (Table 2).
When responses to questions regarding screening were stratified based on subspecialty, only 
30% of general gynecologists and 22.1% of general obstetrics-gynecology providers 
surveyed screen all non-pregnant patients regularly (Table 2). Small percentages of 
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gynecologists and general obstetrics-gynecology practitioners reported that they do not 
regularly screen any patients for IDA. General obstetrics-gynecology practitioners are 
generally divided between those who report screening pregnant patients at the initial visit 
only (49.2%), and those who screen pregnant patients every trimester (47.1%, Table 2). No 
respondents reported “never” screening pregnant women, regardless of specialty.
When responses to questions on screening were stratified by how respondents ranked their 
training on screening, a higher percentage of those who rated their screening training as 
“barely adequate” reported that they screen non-pregnant patients based on symptoms, 
compared with those who rated their training in this area as comprehensive, adequate, or 
inadequate (Table 3).
A majority (61.9%) of respondents that answered a question regarding iron supplementation 
in pregnant women (n = 396) reported that they supplement pregnant patients only when 
there is laboratory evidence of anemia; 31.6% supplement all pregnant patients. Six 
physicians indicated that low-dose iron is typically part of their patients' prenatal vitamins 
and additional supplementation is reserved for evidence of anemia.
Eighty-nine percent (89.7%) of 468 respondents correctly identified altitude as a factor to 
consider when interpreting hemoglobin and hematocrit; 82.9% correctly identified smoking 
history as a factor. Only 38.9% of these respondents correctly identified race as a factor to 
account for in interpretation of results.
Risk factors for IDA in all women of reproductive age were well recognized by respondents. 
A diet poor in iron and heavy menses were the most well recognized risk factors, with 96.1 
and 95.3% of respondents correctly identifying these; over 85% of respondents identified 
gastrointestinal disease affecting absorption and short interpregnancy interval as risk factors, 
while 84.8% recognized heavy blood loss during vaginal delivery. A short interpregnancy 
interval was correctly identified as a risk factor by fewer respondents who rated their 
training in the assessment domain as barely adequate (77.0%) or inadequate (60.0%), and 
only 40.0% of those who rated their training as inadequate recognized heavy blood loss 
during vaginal delivery as a risk factor.
Risk factors for post-partum anemia were correctly recognized by smaller proportions of the 
responding sample. While third trimester anemia was identified as a risk factor for post-
partum anemia by 95.4% of respondents answering this question, multiparity was 
recognized by 73.2%, young age by 57%, income level by 56.2%, and pre-pregnancy obesity 
by only 18.9%. Identification of risk factors for postpartum anemia was lower in the group 
that rated their training on assessment as inadequate, with 83.3% recognizing third trimester 
anemia, 50% recognizing multiparity, 50% young age, and 33.3% income level.
Comment
This survey on knowledge, attitudes and practices regarding IDA among obstetrician-
gynecologists identified gaps in some knowledge areas, suggesting opportunities for 
increased education in these areas, and identified practice pattern variations that may be 
influenced by available recommendations.
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Answers of survey respondents to knowledge questions suggest that there is room for 
improvement in education about IDA, specifically regarding identification of risk factors. 
Although the number of physicians rating their training as inadequate was small, these 
physicians less commonly identified risk factors. Physiologically-based risk factors clearly 
receive emphasis in medical school and residency and are easily recognized. Nearly 85% of 
respondents correctly identified risk factors for IDA among reproductive aged women of all 
races, all of which are related to iron or blood physiology. However, fewer respondents 
correctly identified socio-demographic risk factors. For example, about half of respondents 
did not identify income and educational levels as risk factors for post-partum IDA. Similarly, 
race was recognized by less than half of respondents as a consideration in interpreting 
hemoglobin results, while physiologic factors, like smoking or altitude, were recognized by 
over 80% of respondents. This suggests that increased discussion of socio-demographic 
parameters and the influence of socio-demographic variables on health may be warranted in 
the education of obstetrician-gynecologists, at least with respect to IDA. Additionally, since 
many respondents to our survey report screening non-pregnant and postpartum patients 
based on risk factors, it is imperative that providers recognize as many of those risk factors 
as possible in order to facilitate screening.
Results from this survey indicate that, where there are unclear or conflicting 
recommendations, there are varied and conflicting practices. CDC and the Institute of 
Medicine (IOM) recommend that all women of childbearing age in the United States be 
routinely screened for IDA every 5–10 years without risk factors, and annually with risk 
factors (Centers for Disease Control and Prevention 1998, Institute of Medicine 1993). 
However, ACOG and USP-STF, which have published recommendations on screening 
pregnant women (American College 2008; United States Preventive Services Task Force 
2015), have not issued guidelines for screening nonpregnant women. Because many women 
of childbearing age visit gynecologists regularly, these practitioners are uniquely positioned 
to provide screening services to these women, regardless of their pregnancy status. In our 
survey, only a third of gynecologists and 22.1% of obstetrician-gynecologists screen 
nonpregnant patients regularly; 30.5% of respondents screen for IDA in nonpregnant women 
only when they are symptomatic. Screening nonpregnant patients based on risk factors was 
reported more commonly. Another 3.9% do not screen any patients for IDA as part of 
routine gynecologic visits—and this number is mostly made of up of general practitioners 
within the field of obstetrics-gynecology.
ACOG (American College 2008), IOM (Institute of Medicine 1993) and CDC (1998) 
recommend screening asymptomatic pregnant women for IDA, while the most recent update 
to USPSTF recommendations finds insufficient evidence to endorse doing so (United States 
Preventive Services Task Force 2015). Neither ACOG nor CDC recommendations provide 
information regarding when in pregnancy to screen and whether to screen at multiple points 
in a pregnancy, despite the fact that prevalence of IDA increases across trimesters (Mei et al. 
2011, 15). IOM guidelines recommend screening each trimester. Accordingly, while the 
majority of respondents reported screening pregnant patients, half of these providers screen 
at the initial pregnancy visit, while half screen every trimester.
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Conflicting recommendations exist for supplementation practices, as well. Although the 
USPSTF found insufficient evidence to recommend for or against routine iron 
supplementation in pregnancy (United States Preventive Services Task Force 2015), CDC 
recommends universal supplementation for pregnant women (Centers for Disease Control 
and Prevention 1998). ACOG guidelines note that iron supplementation in pregnancy 
decreases the prevalence of maternal anemia at delivery, but overtly recommend 
supplementation only for women with IDA (American College 2008). IOM guidelines 
endorse supplementation based on hematologic parameters (Institute of Medicine 1993). 
Nearly a third of respondents to our survey follow CDC recommendations, while 61.9% 
supplement when anemia is present.
Although we did not ask practitioners whether they are aware of guidelines for IDA 
screening or supplementation, or what guidelines they follow, practice variation is apparent 
and suggests that providers may be following any one of the many different guidelines. 
These instances indicate the need for further research, both to gain a better understanding of 
physicians' familiarity with the guidelines and how guidelines are incorporated into clinical 
practice, and to identify the most beneficial practices regarding screening and 
supplementation of pregnant women. Large numbers of women may be undergoing 
differential screening and supplementation. Risks and benefits for these women could be 
identified to drive standardization of recommendations. The USPSTF, in its most recent 
update to recommendations, acknowledges the dearth of research in the United States 
population leading to an inability to fully weigh risks and benefits of both screening and 
supplementation practices (United States Preventive Services Task Force 2015).
Further research, however, is unlikely to address the wide variability in practice patterns for 
IDA in the short-term. A reasonable solution could be for stakeholders, including CDC, 
ACOG, IOM and USPTF members, to discuss the evidence base jointly and develop a single 
set of mutually acceptable recommendations, although this would require coordination and 
buy-in at the stakeholder level. More widespread recognition that variable recommendations 
influence the practice patterns of obstetrician-gynecologists may lend a sense of urgency to 
the development of standardized recommendations. At the educational level, alerting 
obstetrics and gynecology physicians-in-training to the multiple and sometimes conflicting 
recommendations could allow more familiarity with recommendations and potentially drive 
further research.
This study has limitations. As a self-reported survey, responses may represent biased 
estimates as opposed to objective data on a participant's practice. The overall response rate 
for this survey is low at 42.4%, and respondents may be intrinsically different than non-
respondents. While approximately two-thirds of respondents were CARN members of 
ACOG, CARN membership is managed in order to provide demographic representativeness 
with ACOG fellows as a whole; ACOG, in turn, represents approximately 90% of US 
obstetrician-gynecologists. Additionally, the sample size of those physicians rating their 
training as “inadequate” is small (n = 7) and conclusions about this group should be viewed 
with caution. The proportion of these physicians who appear to follow recommended 
screening practices may be artificially elevated above the proportions of physicians rating 
their training differently because of the sample size; alternatively, physicians who feel that 
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they received an inadequate amount of training in a particular domain may have put more 
effort into independently studying the various recommendations, and may truly be more 
familiar with them. Importantly, a limitation of our survey is that it did not ask practitioners 
whether they are aware of guidelines for IDA screening or supplementation, or what 
guidelines they follow, if any; this limits the ability to draw firm conclusions about the 
influence of a diversity of professional recommendations regarding IDA, although the 
variability of practice patterns reported does appear to align with various specific 
recommendations.
In conclusion, practitioners of obstetrics and gynecology are in a unique position to provide 
screening, education, and treatment for IDA in women, which continues to contribute to 
morbidity among women of childbearing age in the United States. The survey results 
reported here, from fellows and junior fellows of ACOG, indicate that while training on IDA 
generally provides an appropriate knowledge base for practitioners, there are areas where 
increased education could improve practice; there are also practice variations in both 
screening and supplementation for IDA. Education should stress the variability of 
recommendations for screening and supplementing non-pregnant and pregnant women, and 
should highlight sociodemographic influences on IDA, especially given that much screening 
takes place on the basis of whether risk factors, many of which are socidemographic, are 
present. Finally, further research regarding screening and supplementation practices is 
needed to allow for wider standardization of guidelines.
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Iron deficiency anemia is a major cause of morbidity for women of childbearing age, but 
little is known about knowledge, attitudes and practices related to screening for and 
treatment of this condition. This study provides insight into the practice patterns of 
American obstetrician-gynecologists.
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Table 1
Participant and practice characteristics (n = 503)
Characteristic n or mean Percent or SD *
Birth year (mean) 1957 SD = 10.5
Gender
 Male 257 51.1
 Female 246 48.9
Years in practice since residency (mean) 18.8 SD = 10.4
Current practice
 Solo practice 89 17.7
 Health maintenance organization 10 2.0
 Obstetrics-gynecology partnership/group 232 46.1
 University full-time faculty and practice 60 11.9
 Multi-specialty group 63 12.5
 Other 46 9.1
Primary medical specialty
 General obstetrics-gynecology 365 72.6
 Maternal-fetal medicine 29 5.8
 Obstetrics only 3 0.6
 Reproductive endocrinology 8 1.6
 Gynecology only 81 16.1
 Other 13 2.6
Residence of patients
 Urban 206 40.9
 Suburban 166 33.0
 Mid-sized town 73 14.5
 Rural 36 7.2
 Military 10 2.0
 Other 3 0.6
Percent of patient race/ethnicity in practice (mean)
 Non-Hispanic White 59.3 SD = 27.0
 Hispanic 16.4 SD = 20.3
 African-American 14.8 SD = 15.3
 Native American 1.5 SD = 7.1
 Asian/Pacific Islander 4.9 SD = 8.3
 Other 2.2 SD = 9.5
Patients seen each week (mean) 83.1 SD = 40.6
SD standard deviation
*Some columns do not total 100% because of missing responses
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Table 2
Screening practices of respondents, total and stratified by subspecialty type
Screening practice Overall n (%) Sub-specialty n (%)
(n = 503) Maternal-fetal medicine (n 
= 29)
Gynecology only (n = 81) Obstetrics-gynecology (n = 
365)
Non-pregnant patients n = 482 n = 22 n = 80 n = 358
 Based on risk factors 194 (40.2) 4 (18.2) 36 (45.0) 147 (41.1)
 When symptoms present 147 (30.5) 4 (18.2) 16 (20.0) 119 (33.2)
 All regularly 122 (25.3) 13 (59.1) 24 (30.0) 79 (22.1)
 No patients screened 19 (3.9) 1 (4.5) 4 (5.0) 13 (3.6)
Pregnant patients n = 488 n = 27 n = 80 n = 358
 Do not see pregnant patients 118 (23.5) 1 (3.7) 74 (92.5) 27 (7.5)
n = 370 n = 26 n = 6 n = 331
 Initial visit 185 (50.0) 16 (61.5) 2 (33.3) 163 (49.2)
 Every trimester 171 (46.2) 9 (34.6) 4 (66.7) 156 (47.1)
 When symptoms present 14 (3.8) 1 (3.8) — 12 (3.6)
Postpartum patients n = 397 n = 25 n = 13 n = 348
 Based on risk factors 170 (42.8) 14 (53.8) 5 (38.5) 147 (42.2)
 When symptoms present 111 (28.0) 5 (19.2) — 105 (30.2)
 All regularly 98 (24.7) 6 (23.1) 6 (46.2) 81 (23.3)
 No patients screened 18 (4.5) 1 (3.8) 2 (15.4) 15 (4.3)
Subspecialties reproductive endocrinology, obstetrics only and “other” not included in table; each of these categories had fewer than 15 
respondents. Rows may not total to 100% because of the exclusion of these subspecialty categories
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Table 3
Screening practices of respondents, stratified by rating of education in screening domain
Screening practice Rating of education (screening domain) n(%)
Comprehensive (n = 148) Adequate (n = 296) Barely adequate (n = 41) Inadequate (n = 7)
Non-pregnant patients n = 145 n = 290 n = 41 n = 7
 Based on risk factors 64 (44.1) 112 (38.6) 14 (35.9) 3 (42.9)
 When symptoms present 40 (27.6) 88 (30.3) 17 (43.6) 2 (28.6)
 All regularly 37 (25.5) 76 (26.2) 7 (17.9) 2 (28.6)
 No patients screened 4 (2.8) 14 (4.8) 1 (2.6) —
Pregnant patients n = 146 n = 293 n = 41 n = 7
 Initial visit 63 (43.2) 110 (37.5) 10 (24.4) 2 (28.6)
 Every trimester 55 (37.7) 97 (33.1) 15 (36.6) 4 (57.1)
 When symptoms present 2 (1.4) 11 (3.8) 1 (2.4) —
 Do not see pregnant patients 26 (17.8) 75 (25.6) 15 (36.6) 1 (14.3)
Postpartum patients n = 128 n = 231 n = 32 n = 6
 Based on risk factors 58 (45.3) 93 (40.3) 16 (50.0) 3 (50.0)
 When symptoms present 43 (33.6) 61 (26.4) 7 (21.9) —
 All regularly 25 (19.5) 63 (27.3) 8 (25) 2 (33)
 No patients screened 2 (1.6) 14 (6.1) 1 (3.1) 1 (16.7)
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